COVID-19：Avigan授予38个国家/地区：25EU，6亚洲，5中东
日本政府：
这项赠款将在政府的紧急赠款援助合作框架内实施，总额为100万美元（约合1.1亿日元）。
运输由联合国机构处理。
顺序从完成程序的国家/地区从Avegan发货。
将要求目标国家提供有关行政效果的数据，这些数据将用于增强日本的知识。
外交部长莫吉：
已经出现了许多具有治疗作用的病例。
他说，他希望不仅在日本而且在国际上扩大临床研究。
厚生劳动省：
研究参与指南已编制并于27日通知全国医疗机构，以供Abigan批准。
通过尽快收集大量临床数据来加速分析。
已经有大约1100家医疗机构参加了这项研究，并已向2000多人进行了管理。
研究目标：使用Avgigan
经医疗机构/道德审查委员会事先批准
患者同意书
向厚生劳动省研究小组提供数据
读卖新闻在线
https://www.yomiuri.co.jp/politics/20200428-OYT1T50212/
Japan to offer anti-flu drug Avigan to 38 countries as early as this week
APR 29, 2020
Japan will begin providing the anti-flu drug Avigan for free to 38 countries
as early as this week for treating patients with the new coronavirus, according to Foreign Minister Toshimitsu Motegi.
At a news conference Tuesday, Motegi also
said over 70 countries,
including the 38, have made requests for Avigan to Japan, which has decided to offer a $1 million grant to the United Nations Office for Project Services to buy and distribute the drug, also known as favipiravir, to countries that want it.
“I’ve heard that (the U.N. agency) is arranging to start transporting the drug around the holidays after procedures have been completed,”
Motegi told the news conference, referring to the last five days of the Golden Week holidays from Saturday through next Wednesday.
Among the 38 nations are
25 European countries, mostly from Eastern Europe,
six in Asia including the Philippines and Malaysia,
five in the Middle East such as Kuwait and two from other regions,
Motegi said
Japan will be provided with data obtained from clinical tests on COVID-19 patients that will be conducted in the recipient countries using the drug, which was developed by a group firm of Fujifilm Holdings Corp.
The Japan Times
https://www.japantimes.co.jp/news/2020/04/29/national/japan-avigan-drug-38-countries/#.XqowR0FcWEd